Menu

Alix PESLERBE

AQUITAINE

En résumé

-CA/EC/CNOM/CNIL/CCTIRS submission

-Site selection including identification and feasibility

-Study documents updating according to local specificities and regulation (Informed Consent Form, study drug labels)

-Performing the financial agreements/contracts with sites according to local specificities and regulation (investigator, institution/hospital and association contracts)

- Site management activities include all in house and on-site monitoring for all visit types according to ICH guidelines, local regulations, as well as FDA regulations (state and local laws), GCPs and SOPs

-Performing all other site monitoring activities (investigative site file reconciliation, Serious Adverse Event (SAE) reporting, study logistic and material)

Mes compétences :
CNIL

Entreprises

  • CLINICAL RESEARCH CONSULTING - SENIOR CLINICAL RESEARCH ASSOCIATE

    maintenant Since 2005: Freelance Clinical Research Associate

    * International CRO, since January 2011, Cardiac Electrophysiology, medical devices
    -Site management activities include all in house and on-site monitoring for all visit types

    * International CRO, From June to October 2010, Orthopaedics, medical devices, responsible of Start-up Activities (EC/CA/CNOM/CNIL)

    * International CRO, from May 2009 to June 2011, Cardiology, medical devices
    -Site management activities include all in house and on-site monitoring for all visit types

    * International CRO, since 2007 to April 2011, medical device in various therapeutic areas for phase II to IV studies:
    -Study documents updating according to local specificities and regulation
    -AFSSAPS and EC submission, Budget negotiation, CNOM submission
    -Site management activities include all in house and on-site monitoring for all visit types

    * Pharmaceutical Company, since 2008 to January 2011, International phase III study in aneurismal subarachnoid haemorrhage

    * International CRO, since May 2009 to Feb 2010, Oncology(CLL)
    -Site selection including identification and feasibility
    -Study documents updating according to local specificities and regulation (Informed Consent Form, patient’s documentation)
    -Performing the agreements with sites according to local specificities and regulation (investigator, institution and association contracts)
    -Responsible for EC’s submission

    * International CRO, since 2006 to 2007, International phase III study in Oncology (NSCLC)
    -Site management activities include all in house and on-site monitoring for all visit types

    * French CRO, since 2005 to 2009: National phase III and IV studies in gastroenterology (RGO), Diabetology and Pneumology (asthma),
    -Site management activities include all in house and on-site monitoring for all visit types

    * Pharmaceutical Company, since 2005 to 2008 International phases I /II studies in Rheumatology:
    -Responsible for EC’s submission
    -Site management activities include all in house and on-site monitoring for all visit types
    -Study documents updating according to local specificities and regulation
    -Performing the agreements with sites according to local specificities and regulation (investigator, institution and association contracts)


    March 2003 to 2004: Home-based Clinical Research Associate, International CRO
    - National clinical trial monitoring for a French phase III study in Cardiology (150 sites) for all visit types

    June 2001 to February 2003: Clinical Trial Associate, Pharmaceutical Company, Eastern Europe countries, international phase III studies in Gynaecology, Cardiology, Endocrinology
    -International clinical trial monitoring in compliance with local regulatory requirements, regulatory documents submission, financial aspects follow-up, investigator’s meeting, and audit
    -Site management activities include all in house and on-site monitoring for all visit types

    1999 to 2000: Clinical Research Associate, University Hospital, Clinical research centre, Haematology /Oncology
    -Site management, Responsible for completing CRFs for studies in the field of CML

Formations

Réseau

Annuaire des membres :